Omidubicel, sold under the brand name Omisirge, is a blood-based cell therapy used for the treatment of blood cancers. Omidubicel is a nicotinamide-modified...

allogeneic cell therapies have been developed, Prochymal and Cartistem. Omidubicel was approved for medical use in the United States in April 2023. To limit...